Market Analysis
The global amyotrophic lateral sclerosis market is anticipated to
touch USD 841.6 million at a healthy 7.89% CAGR during the forecast
period (2018-2023). ALS or Amyotrophic Lateral Sclerosis is a
neurological ailment which affects the nerve cells in the spinal cord
and the brain that controls the voluntary muscles’ activities. Some of
the common symptoms of ALS include cramps, muscle weakness, respiratory
problems, and fasciculation. This is a progressive neurological disease
where gradually patients become dependent on physicians and caregivers
increasingly. Often ALS results in respiratory failure as the patient
loses the ability of controlling the muscles both in the diaphragm and
the chest. Ultimately, it turns fatal.
Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/5822
There are many factors that are driving the growth of the amyotrophic
lateral sclerosis market. Some of these factors as per the Market
Research Future (MRFR) report include rising incidences of ALS, increase
in awareness among patients, increase in geriatric population, FDA
approvals and initiatives taken by the government on R&D activities.
On the other hand, factors such as low treatment availability and high
treatment cost may hinder the growth of the amyotrophic lateral
sclerosis market.
Amyotrophic Lateral Sclerosis Market Segmentation
The amyotrophic lateral sclerosis market has been segmented based on type, treatment, end-user, and regions.
By type, the amyotrophic lateral sclerosis market has been segmented
into sporadic ALS and familial ALS. The Sporadic ALS segment is
dominating the market. The prevalence of sporadic ALS is relatively high
and almost 90% of the cases are sporadic. The cause of sporadic ALS
remains unknown and a combination of genetic and environmental risk
factors are presumed to be the underlying cause of the diseases. The
occurrence of familial ALS is very low and are inherited from genetic
mutations.
By treatment, the amyotrophic lateral sclerosis market has been
segmented into medication, physical therapy, respiratory therapy, speech
therapy, and others. The medication segment is dominating the market as
most patients opt for medicines a s a treatment method. Medications are
effective and economical.
By end-user, the amyotrophic lateral sclerosis market has been
segmented into hospitals, specialty centers, research & academic
institutes, and others. The hospitals segment is domineering the
markets. Hospitals are generally the first point of treatment and are
highly proffered by patients.
Regional Analysis
Based on region, the amyotrophic lateral sclerosis market covers
growth opportunities and latest trends across North America, Europe,
Asia Pacific, and the Middle East and Africa. Of these, North America
will lead the market during the forecast period owing to support from
the government for R&D, rising pool of awareness, the existence of
many leading market players, increasing incidence of hypertension, and
advanced medical facilities. Canada and the USA are the largest
contributors in this region. Europe will have the second largest share
in the amyotrophic lateral sclerosis market during the forecast period.
The UK, Germany, and France will be the largest contributors in this
region. In the APAC region, the amyotrophic lateral sclerosis market is
anticipated to grow rapidly owing to the rapidly expanding healthcare
infrastructure, increasing the incidence of ALS, the presence of the
growing economies mainly India and China, and increasing setups of
R&D centers. South Korea, Japan, and Australia are the other vital
country-specific markets here. On the other hand, the amyotrophic
lateral sclerosis market in the Middle East and Africa will have the
smallest share owing to poor countries, inadequate healthcare
facilities, lack of education, medical facilities having low standard,
lack of awareness and lack of advanced and innovative medical
facilities.
Amyotrophic Lateral Sclerosis Market Competitive Landscape
ITF Pharma (USA), Sanofi (France), Mylan N.V. (USA), Mitsubishi
Tanabe Pharma America (USA), Ionis Pharmaceutical (USA), Sun
Pharmaceutical (India), Ascend Pharmaceuticals LLC (USA), and Apotex
Inc. (Canada), Covis Pharma (Switzerland), and Biogen (USA) are the key
players in the amyotrophic lateral sclerosis market.
Industry Updates
August 2019 – Scientists from the Peking Union Medical College
Hospital in China have identified a new type of split-hand index that
can assist in distinguishing people with amyotrophic lateral sclerosis
at an early stage.
List of Tables
TABLE 1 MARKET SYNOPSIS 15
TABLE 2 LIST OF ASSUMPTIONS 17
TABLE 3 GLOBAL ALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 34
TABLE 4 GLOBAL ALS MARKET FOR SPORADIC ALS, BY REGION, 2020–2027 (USD MILLION) 35
TABLE 5 GLOBAL ALS MARKET FOR FAMILIAL ALS, BY REGION, 2020–2027 (USD MILLION) 35
Browse Complete Report @ https://www.marketresearchfuture.com/reports/amyotrophic-lateral-sclerosis-market-5822
Get Our More Trending Research Report Here:-
Compression Therapy Market
eClinical Solutions Market
Acromegaly Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel
the complexity of various industries through our Cooked Research Report
(CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting
Services. MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable
our clients to see more, know more, and do more, which help to answer
all their most important questions. In order to stay updated with
technology and work process of the industry, MRFR often plans &
conducts meet with the industry experts and industrial visits for its
research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
https://marketreports4u.blogspot.com/
Comments
Post a Comment